User profiles for Taro Yamashita
Taro YamashitaProfessor, Tohoku University Verified email at tohoku.ac.jp Cited by 6144 |
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features
T Yamashita, J Ji, A Budhu, M Forgues, W Yang… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Cancer progression/metastases and embryonic development share
many properties including cellular plasticity, dynamic cell motility, and integral interaction …
many properties including cellular plasticity, dynamic cell motility, and integral interaction …
[HTML][HTML] Chip-based quantum key distribution
Improvement in secure transmission of information is an urgent need for governments,
corporations and individuals. Quantum key distribution (QKD) promises security based on the …
corporations and individuals. Quantum key distribution (QKD) promises security based on the …
[PDF][PDF] Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells
J Ji, T Yamashita, A Budhu, M Forgues, HL Jia… - …, 2009 - Wiley Online Library
MicroRNAs (miRNAs) are endogenous small noncoding RNAs that regulate gene expression
with functional links to tumorigenesis. Hepatocellular carcinoma (HCC) is the most …
with functional links to tumorigenesis. Hepatocellular carcinoma (HCC) is the most …
[HTML][HTML] Cancer stem cells in the development of liver cancer
T Yamashita, XW Wang - The Journal of clinical …, 2013 - Am Soc Clin Investig
Liver cancer is an aggressive disease with a poor outcome. Several hepatic stem/progenitor
markers are useful for isolating a subset of liver cells with stem cell features, known as …
markers are useful for isolating a subset of liver cells with stem cell features, known as …
Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE
…, HY Dong, J Sakai, T Yamashita… - Blood, The Journal …, 2000 - ashpublications.org
Monocytes play a pivotal role in various human infectious and inflammatory diseases. To
reveal a whole picture of pathophysiologic function of activated human monocytes, this study …
reveal a whole picture of pathophysiologic function of activated human monocytes, this study …
Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma
T Yamashita, M Honda, H Takatori, R Nishino… - Journal of …, 2009 - Elsevier
BACKGROUND/AIMS: Metabolic dysregulation is one of the risk factors for the development
of hepatocellular carcinoma (HCC). We investigated the activated metabolic pathway in …
of hepatocellular carcinoma (HCC). We investigated the activated metabolic pathway in …
EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma
T Yamashita, M Forgues, W Wang, JW Kim, Q Ye, H Jia… - Cancer research, 2008 - AACR
The heterogeneous nature of hepatocellular carcinoma (HCC) and the lack of appropriate
biomarkers have hampered patient prognosis and treatment stratification. Recently, we have …
biomarkers have hampered patient prognosis and treatment stratification. Recently, we have …
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial
…, L Obici, Y Sekijima, SR Zeldenrust, T Yamashita… - Jama, 2013 - jamanetwork.com
Importance Familial amyloid polyneuropathy, a lethal genetic disease caused by aggregation
of variant transthyretin, induces progressive peripheral nerve deficits and disability. …
of variant transthyretin, induces progressive peripheral nerve deficits and disability. …
[PDF][PDF] A liver-derived secretory protein, selenoprotein P, causes insulin resistance
…, M Sakurai, T Yamashita, E Mizukoshi, T Yamashita… - Cell metabolism, 2010 - cell.com
The liver may regulate glucose homeostasis by modulating the sensitivity/resistance of
peripheral tissues to insulin, by way of the production of secretory proteins, termed hepatokines. …
peripheral tissues to insulin, by way of the production of secretory proteins, termed hepatokines. …
Activation of hepatic stem cell marker EpCAM by Wnt–β-catenin signaling in hepatocellular carcinoma
T Yamashita, A Budhu, M Forgues, XW Wang - Cancer research, 2007 - AACR
The heterogeneous nature of hepatocellular carcinoma (HCC) and the lack of appropriate
biomarkers have hampered patient prognosis and treatment stratification. Using a gene …
biomarkers have hampered patient prognosis and treatment stratification. Using a gene …